Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer

MedSIR investigative site, Cáceres

MedSIR investigative site, Torino

MedSIR investigative site, Prague

MedSIR investigative site, Castelló

MedSIR investigative site, Córdoba

MedSIR investigative site, Prague

MedSIR investigative site, Santiago de Compostela

MedSIR investigative site, Girona

MedSIR investigative site, Monza

MedSIR investigative site, Milan

MedSIR investigative site, Milan

MedSIR investigative site, Huelva

MedSIR investigative site, Cremona

MedSIR investigative site, Madrid

MedSIR investigative site, Pamplona

MedSIR investigative site, Toulouse

MedSIR investigative site, Oviedo

MedSIR investigative site, Seville

MedSIR investigative site, Modena

MedSIR investigative site, Tarragona

MedSIR investigative site, Valencia

MedSIR investigative site, Bilbao

MedSIR investigative site B, Zaragoza

MedSIR investigative site, Zaragoza

MedSIR investigative site, Strasbourg

MedSIR investigative site, Heidelberg

MedSIR investigative site, Brindisi

MedSIR investigative site, Paris

MedSIR investigative site, Paris

MedSIR investigative site, Paris

MedSIR investigative site, Olomouc

MedSIR investigative site, Moscow

MedSIR investigative site, Moscow

MedSIR investigative site, Yaroslavl

MedSIR investigative site, Saint Petersburg

MedSIR investigative site, Dessau

MedSIR investigative site, Cagliari

MedSIR investigative site, Piacenza

MedSIR investigative site, Barcelona

MedSIR investigative site, Barcelona

MedSIR investigative site, Barcelona

MedSIR investigative site, Bath

MedSIR investigative site, London

MedSIR investigative site, Manchester

MedSIR investigative site, Nottingham

MedSIR investigative site, Romford

MedSIR investigative site, Swansea

MedSIR investigative site, Truro